Offer - Urjas Oil for just ₹ 1
Lariago Suspension, a prescription drug, is manufactured in various forms such as Suspension. Primarily, it is used for the treatment of Malaria.
The optimal dosage of Lariago Suspension is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Lariago Suspension as well, which are listed below. Usually, these side effects of Lariago Suspension go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Lariago Suspension's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Lariago Suspension has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Lariago Suspension related warnings section.
Lariago Suspension is contraindicated in people with pre-existing medical conditions like Porphyria as it can result in adverse effects. Other contraindications of Lariago Suspension have been discussed in the sections ahead.
Besides this, Lariago Suspension may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Lariago Suspension is considered not safe while driving, and is not addictive.
Lariago Suspension is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Lariago Suspension safe for pregnant women?
Lariago should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Lariago Suspension safe during breastfeeding?
Lariago may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Lariago Suspension on the Kidneys?
There may be some adverse effects on kidney after taking Lariago. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Lariago Suspension on the Liver?
You may experience side effects on your liver after taking Lariago. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Lariago Suspension on the Heart?
There may be an adverse effect on the heart after taking Lariago. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Lariago Suspension unless your doctor advises you to do so -
Is this Lariago Suspension habit forming or addictive?
No, you will not get addicted to Lariago Suspension.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Lariago Suspension as you may feel sleepy.
Is it safe?
Yes, but consume Lariago Suspension only on doctor's advice.
Is it able to treat mental disorders?
Lariago Suspension is unable to treat or cure mental disorders.
Interaction between Food and Lariago Suspension
Information is not available on the interaction of any foods with Lariago Suspension, due to a lack of research on this.
Interaction between Alcohol and Lariago Suspension
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Lariago Suspension.
Yes, Lariago can be taken with diclofenac. No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking this drug do not hesitate to inform your doctor.
Yes, Lariago can affect blood sugar levels. It has been reported to lower the blood sugar levels (hypoglycemia). So, if you have diabetes keep a check on your blood sugar levels and in case if you feel lightheadedness, shaking or increased heartbeat after taking this drug then drink a glass of fruit juice, eat candies to restore your blood sugar levels and report to your doctor.
Rarely, Lariago causes hair loss (alopecia). This problem goes away after discontinuation of this drug. For partial hair loss, you are advised to use hair tonic and discuss with the doctor for best possible treatment to hair loss.
Take Lariago as directed by your doctor. Do not take this medicine longer than prescribed to avoid unpleasant side effects.
Lariago is a brand name of chloroquine and it comes in the form of a tablet, capsule, injection, and oral suspension. It belongs to the class of drugs known as antimalarials which have amebicidal activity. It is a prescription drug that is used in the treatment of malaria which is a vector-borne infectious disease caused by parasites Plasmodium species. These are Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, and Plasmodium vivax. Apart from this Lariago is also used in the treatment of extraintestinal amebiasis which is the protozoal infection caused by parasite Entamoeba histolytica. It is also used in the treatment of rheumatoid arthritis and systemic lupus erythematosus (SLE) both are autoimmune diseases which causes inflammation and pain. Lariago is also used off-label for the treatment of porphyria cutanea tarda (PCT) a blood disorder that affects the skin.
This medicine data has been created by -
References
KD Tripathi. Package leaflet information for the user; Aralen® Chloroquine phosphate. Eighth Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2019
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 211